Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2013 $ 6,512,000 $ 0 $ 6,000 $ 33,235,000 $ (1,000) $ (26,728,000)
Balance (in shares) at Dec. 31, 2013   0 5,834,081      
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) 4,889,000 0 1,000 4,888,000 0 0
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) (in shares)   0 1,150,475      
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 40,654,000 0 3,000 40,651,000 0 0
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 (in shares)   0 2,898,550      
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) 608,000 0 0 608,000   0
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) (in shares)   0 50,000      
Stock based compensation 1,204,000 0 0 1,204,000 0 0
Foreign currency translation adjustment 5,000 0 0 0 5,000 0
Net loss (11,208,000) 0 0 0 0 (11,208,000)
Balance at Jun. 30, 2014 $ 42,664,000 $ 0 $ 10,000 $ 80,586,000 $ 4,000 $ (37,936,000)
Balance (in shares) at Jun. 30, 2014   0 9,933,106